logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Medications for Lupus Nephritis

    FiltersReset Filters
    5 results

    • benlysta

      (belimumab)
      GlaxoSmithKline LLC
      Usage: BENLYSTA (belimumab) is indicated for patients aged 5 and older with active systemic lupus erythematosus and active lupus nephritis, both receiving standard therapy. Its efficacy in severe active central nervous system lupus is not evaluated, hence it is not recommended for such cases.

    • dexamethasone

      (dexamethasone)
      Amneal Pharmaceuticals NY LLC
      Usage: This drug is indicated for severe allergic conditions, dermatologic and endocrine disorders, gastrointestinal issues, hematologic disorders, certain cancers, acute nervous system conditions, ocular inflammation, renal diseases, respiratory conditions, and as adjunctive therapy for rheumatic disorders. It addresses various severe and chronic health issues unresponsive to standard treatments.

    • lupkynis

      (Voclosporin)
      Aurinia Pharma U.S., Inc.
      Usage: LUPKYNIS is indicated for the treatment of adult patients with active lupus nephritis (LN) in combination with a background immunosuppressive therapy. Its safety and efficacy have not been established with cyclophosphamide, and its use in this context is not recommended.

    • methylprednisolone acetate

      (Methylprednisolone acetate)
      Amneal Pharmaceuticals NY LLC
      Usage: Methylprednisolone acetate injectable suspension is indicated for intramuscular, intra-articular, and intralesional administration to treat severe allergic conditions, dermatologic and endocrine disorders, gastrointestinal diseases, hematologic disorders, rheumatic conditions, neoplastic diseases, and specific ophthalmic and respiratory diseases, among others.

    • prednisolone sodium phosphate

      (Prednisolone Sodium Phosphate)
      PAI Holdings, LLC
      Usage: Prednisolone sodium phosphate oral solution is indicated for severe allergic conditions, dermatologic and endocrine disorders, gastrointestinal diseases, hematologic disorders, neoplastic diseases, acute multiple sclerosis exacerbations, ocular inflammation, respiratory diseases, rheumatic disorders, and specific miscellaneous conditions involving tuberculosis and organ rejection.